Mary-Elizabeth M Percival (Mary-Elizabeth Percival)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Leukemia & lymphoma

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle Y Zhang, Megan K D Othus, Kerry McMillen, Harry P Erba, Guillermo Garcia Manero, John M Pagel, Mohamed L Sorror, Mary-Elizabeth M Percival
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203. Leukemia (2024)
Michelle Y Zhang, Megan K D Othus, Kerry McMillen, Harry P Erba, Guillermo Garcia Manero, John M Pagel, Mohamed L Sorror, Mary-Elizabeth M Percival
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203. Leukemia 38 (7) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Michelle Y Zhang, Megan K D Othus, Kerry McMillen, Harry P Erba, Guillermo Garcia Manero, John M Pagel, Mohamed L Sorror, Mary-Elizabeth M Percival
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203. Leukemia (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Noam E Kopmar, Xiaoyu Qu, Yajuan Liu, Ted A Gooley, Cristina M Ghiuzeli, Raya Mawad, Mary-Elizabeth M Percival, Min Fang, Ryan D Cassaday
Prognostic significance of chromosomal genomic array testing in adults with newly-diagnosed acute lymphoblastic leukemia. Leukemia & lymphoma (2024)
Michelle Y Zhang, Megan K D Othus, Kerry McMillen, Harry P Erba, Guillermo Garcia Manero, John M Pagel, Mohamed L Sorror, Mary-Elizabeth M Percival
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203. Leukemia 38 (7) (2024)
Michelle Y Zhang, Megan Othus, Carole Shaw, Kelda G Schonhoff, Anna B Halpern, Jacob Appelbaum, Paul C Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents. Leukemia & lymphoma (2023)
Noam E Kopmar, Ted Gooley, Niall Curley, Kathryn Russell, Carole Shaw, Kelda Schonhoff, John Lim, Anna B Halpern, Roland Bruno Walter, Bart L Scott, Jacob Appelbaum, Paul C Hendrie, Elihu H Estey, Mary-Elizabeth M Percival
Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms. Leukemia & lymphoma (2023)
Lauren Shih, Megan Othus, Kelda Schonhoff, Carole Shaw, Jacob S Appelbaum, Anna B Halpern, Pamela S Becker, Roland Bruno Walter, Elihu Estey, Mary-Elizabeth M Percival
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms. Leukemia (2023)
Ryan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, Olga Sala-Torra, Philip A Stevenson, Christen H Martino, Yajuan J Liu, Min Fang, Mary-Elizabeth M Percival, Anna B Halpern, Pamela S Becker, Vivian G Oehler, Andrei R Shustov, Jason P Cooper, Johnnie J Orozco, Paul C Hendrie, Roland Bruno Walter, Jerald P Radich, Lorinda A Soma, Elihu H Estey
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia. Leukemia & lymphoma (2023)
Gabrielle Paras, Megan Othus, Kelda Schonhoff, Carole Shaw, Mohamed Lotfy Sorror, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms. Leukemia (2022)
Nicole Mostofi, Carole Shaw, Roland Bruno Walter, Mary-Elizabeth M Percival, Elihu H Estey
Evaluating concordance in assessment of ECOG performance status in acute myeloid leukemia patients. Leukemia 36 (10) (2022)
Noam E Kopmar, Megan K D Othus, Kelda M Gardner, Carole Shaw, Anna B Halpern, Bart L Scott, Paul C Hendrie, Roland Bruno Walter, Pamela S Becker, Elihu H Estey, Mary-Elizabeth M Percival
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies. Leukemia 36 (4) (2022)
Mary-Elizabeth M Percival, Hai-Lin Wang, Mei-Jie Zhang, Wael Saber, Marcos J deLima, Mark Litzow, Partow Kebriaei, Hisham Abdel-Azim, Kehinde Adekola, Mahmoud Aljurf, Ulrike Bacher, Sherif M Badawy, Amer Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Paul Castillo, Nelson Chao, Saurabh Chhabra, Edward Copelan, Corey Cutler, Zachariah DeFilipp, Ajoy Dias, Miguel Angel Diaz, Elihu Estey, Nosha Farhadfar, Haydar A Frangoul, César O Freytes, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael Richard Grunwald, Nasheed M Hossain, Rammurti T Kamble, Christopher G Kanakry, Ankit Kansagra, Mohamed A Kharfan-Dabaja, Maxwell Krem, Hillard M Lazarus, Jong Wook Lee, Jane L Liesveld, Richard J Lin, Hongtao Liu, Joseph P McGuirk, Reinhold Munker, Hemant S Murthy, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Neil Palmisiano, Jakob R Passweg, Tim Prestidge, Olle Ringdén, David A Rizzieri, Witold B Rybka, Mary Lynn Savoie, Kirk R Schultz, Sachiko Seo, Akshay Sharma, Melham M Solh, Roger Strair, Marjolein van der Poel, Leo F Verdonck, Jean A Yared, Daniel J Weisdorf, Brenda M Sandmaier
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation. Bone marrow transplantation 56 (9) (2021)
Mary-Elizabeth M Percival, Elihu H Estey
Are phase III trials still important for FDA drug approval? Leukemia & lymphoma 62 (6) (2021)
Anna B Halpern, Megan Othus, Nicholas P Howard, Paul C Hendrie, Mary-Elizabeth M Percival, Garrett A Hartley, Verna L Welch, Elihu H Estey, Roland Bruno Walter
Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy. Leukemia & lymphoma (2021)
Michael J Hochman, Megan Othus, Roland B Walter, Carole Shaw, Kelda Gardner, Mary-Elizabeth M Percival, Anna B Halpern, Paul C Hendrie, Brenda M Sandmaier, Elihu H Estey
Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML). Leukemia & lymphoma 62 (6) (2021)
Mohamed Lotfy Sorror, Shirali Agarwal, Megan K D Othus, Ylinne Lynch, Jennifer E Nyland, Mary-Elizabeth M Percival, Pamela S Becker, Frederick R Appelbaum, Elihu H Estey
Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML. Cancer medicine 9 (18) (2020)
Anna B Halpern, Megan Othus, Nicholas P Howard, Paul C Hendrie, Mary-Elizabeth M Percival, Bart L Scott, Terry B Gernsheimer, Nikita V Baclig, Sarah A Buckley, Ryan D Cassaday, Garrett A Hartley, Verna L Welch, Elihu H Estey, Roland B Walter
Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms. Leukemia & lymphoma 62 (1) (2020)
Mary-Elizabeth M Percival, Elihu H Estey
Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia. Cancer 125 (18) (2019)
Sarah A Buckley, Mary-Elizabeth M Percival, Megan Othus, Anna B Halpern, Emily M Huebner, Pamela S Becker, Carole Shaw, Mazyar Shadman, Roland B Walter, Elihu H Estey
A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Leukemia & lymphoma 60 (4) (2018)